Target intelligence / Profile preview

Monoclonal paraprotein (M protein)

Target
M protein
Molecular classification
Immunoglobulin (antibody), Light chain (Bence Jones protein), Heavy chain
01

Overview

A **monoclonal paraprotein** is an abnormal antibody or antibody fragment produced in excess by a single clone of plasma cells. It is most commonly detected as part of disorders such as **multiple myeloma**, **MGUS** (monoclonal gammopathy of undetermined significance), Waldenström macroglobulinemia, amyloidosis, and other related hematologic diseases. These proteins are also called **M proteins**, **paraproteins**, or **myeloma proteins**. Unlike normal polyclonal antibodies that help fight infection as part of the immune system’s response to pathogens, monoclonal paraproteins are usually non-functional—they do not participate effectively in immune defense. Their presence reflects an underlying clonal proliferation disorder involving B-cells/plasma cells. Paraproteins can be whole immunoglobulin molecules or just fragments such as light chains (“Bence Jones” proteins) or heavy chains. They may be found incidentally during blood tests for unrelated reasons since many people with MGUS have no symptoms. However, high concentrations can lead to clinical problems including increased blood viscosity (“hyperviscosity syndrome”), kidney damage from deposition in renal tubules (“cast nephropathy”), suppression of normal antibody production leading to increased infection risk, neuropathy if they deposit on nerves (“amyloid neuropathy”), and other organ dysfunctions depending on where they accumulate. The detection and quantification of these abnormal proteins serve primarily as diagnostic biomarkers rather than therapeutic targets themselves—treatment focuses on eliminating the malignant plasma cell clone responsible for their production.

Other names
ParaproteinM proteinMonoclonal proteinMyeloma proteinM componentM spike
02

Biological functions

Immune response (normal function of immunoglobulins/antibodies)
03

Disease associations

Cancer (Multiple myeloma, Waldenström macroglobulinemia, plasmacytoma)Pre-malignant conditions (Monoclonal gammopathy of undetermined significance [MGUS], Monoclonal gammopathy of renal significance [MGRS])Amyloidosis
04

Biomarkers

Serum/urine electrophoresis for detection and quantification of paraprotein/M-proteinSerum free light-chain assay for Bence Jones proteins

Beyond the preview

Go deeper on Monoclonal paraprotein (M protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monoclonal paraprotein (M protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call